Skip to content
My WebMD Sign In, Sign Up

Alzheimer's Disease Health Center

Font Size
A
A
A

Alzheimer's Drug Slows Memory Decline

Other Alzheimer's Drugs in Late-Stage Testing continued...

Also at the meeting, researchers offered an update on another drug called bapineuzumab, which targets beta-amyloid in the brain.

In August, researchers reported that patients taking bapineuzumab didn't fare any better in terms of memory loss or daily functioning than those taking placebo.

Reisa Sperling, MD, director of the Center for Alzheimer's Research and Treatment at Brigham and Women's Hospital in Boston, now reports that imaging studies show bapineuzumab reduces beta-amyloid more than placebo.

Is the lack of a bigger effect in terms of reducing symptoms because "we are giving too little of the drug or giving the drug too late?" she asks.

"Hopefully, these new results from the bapineuzumab studies together with the clinical results from the solanezumab studies may provide a potential path forward for Alzheimer's research,'' Sperling says.

No cost has been set for either drug, but targeted disease-modifying drugs used to treat arthritis generally cost hundreds of dollars a month.

These findings were presented at a medical conference. They should be considered preliminary, as they have not yet undergone the "peer review" process, in which outside experts scrutinize the data prior to publication in a medical journal.

1 | 2

Today on WebMD

alzheimer's disease warning signs
ARTICLE
Alzheimers Overview
SLIDESHOW
 
Best Memory Boosting Games
ARTICLE
Alzheimers Dementia
ARTICLE
 
daughter and father
ARTICLE
senior man
ARTICLE
 
Making Diagnosis
Article
caregiver
ARTICLE
 
Woman comforting ailing mother
ARTICLE
mri scan of human brain
QUIZ
 
senior woman with lost expression
ARTICLE
Antioxidants Memory
ARTICLE